GENEGUT Attends Kerry Patient Day 2026 to Support Dialogue on IBD Care and Research
GENEGUT was pleased to take part in the first-ever Kerry Patient Day 2026, organised by Crohn’s & Colitis Ireland (CCI) at the Brehon Hotel in Killarney.
GENEGUT successfully showcases oral RNA delivery research at PBP World Meeting 2026 in Prague
GENEGUT was strongly represented at the 15th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology (PBP World Meeting 2026), held in Prague, Czech Republic, from 23 to 26 March 2026.
Sophia Hoffmann presents GENEGUT research on gastric emptying at AAPS PharmSci 360 2025
Sophia Hoffmann from University College Cork presented her latest research at the AAPS PharmSci 360 Conference, held in San Antonio, Texas (USA) from 9–12 November 2025.
GENEGUT Patient Survey | Bangor University & IFCCA
If you are living with Crohn’s disease, we invite you to take part in a new survey that will help shape the development of future treatments.
GENEGUT to showcase oral RNA delivery research at PBP World Meeting 2026 in Prague
GENEGUT will be strongly represented at the 15th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology (PBP World Meeting 2026), taking place in Prague, Czech Republic, from 23 to 26 March 2026.
Updates from our partners at CarboHyde: Expanding Innovation in cyclodextrin science
Our partners from CarboHyde enter 2026 with a strong pipeline of initiatives reinforcing its position in cyclodextrin chemistry, advanced drug delivery and translational pharmaceutical development.